Pleomorphic adenoma is the most common benign salivary neoplasm (
4). Although clinically and histologically it is a benign tumour, there are rare reports of metastasis to regional and distant sites, in which the metastatic foci are histologically identical to the benign primary tumour (
2,
3). Benign MPA is distinguished from truly malignant pleomorphic tumors (such as carcinomas arising from pleomorphic adenomas, and carcinosarcomas) by its benign histologic features. However, there are no agreed histopathologic parameters that can differentiate a nonmetastatic pleomorphic adenoma from Mpa (
4,
5,
8). It has been suggested that metastasising tumours have a higher mitotic rate than non-recurring lesions, but this theory is not universally accepted and this feature was not seen in our patient (
6-
9). The Patients (81%) with MPA have a history of at least one local recurrence of PA prior to the detection of distant metastasis of the tumour at the primary site is a characteristic feature of these metastasising pleomorphic adenomas; recurrence ocurring in about 90% of cases (
5). There is often a long interval between the diagnosis of the primary mixed tumour and the metastasis (
5,
6). Paradoxical nature of MPA, with its benign histological appearance and its metastatic spread capacity, intrigues clinicians and academic scholars. Several hypotheses have been formulated in order to explain how a histological benign tumor may produce metastasis, such as previous radiation of the primary PA or previous surgical intervention that should favor seeding and permeation of blood or lymphatic vessels by tumor cells, followed by metastatic spread (
2,
7-
9). However, the data in literature have shown that they are not absolute requisites for metastatic disease to occur (
2,
4,
5). Tumour enucleation should never be performed as it increases local recurrence rate. Local recurrence may be the first step in the dissemination of these neoplasms and therefore radical surgery and radiotherapy should be considered in these cases (
6,
7). Clinical rather than pathologic evidence seems to justify inclusion of metastasizing salivary pleomorphic adenoma in the group of low-grade malignant salivary tumors (
7-
9).